FGL1 and neoplasm: Upon engagement with MHC class II molecules, or its newly described ligand, fibrinogen-like protein 1 (FGL1), LAG-3 negatively regulates T and NK cells, thereby promoting tumor escape likely by promoting exhaustion in combination with other checkpoints such as PD1 [17,18,19].